论文部分内容阅读
制药企业正面临着巨大的挑战,包括工作效率下降、创新能力降低、关键专利到期、仿制药的价格竞争激烈、较高的监管障碍,以及不良的企业形象。必须进行革新来应对这些挑战。制药企业已采取一系列应对措施。然而,长久以来评论家的指控已使制药企业声誉受损。本系列包括两部分内容,第一部分将讨论制药企业受到的批评,并总结这些批评的支持与反对依据。第二部分将讨论制药企业目前面临的挑战及采取的应对措施,即通过改变企业观念并采用新的商业模式来应对近来人才流失和进入临床试验的新药减少的状况,也提出了一些近期药物发现的成功实例。
Pharmaceutical companies are facing immense challenges, including reduced work efficiency, lower innovation capacity, expired key patents, fierce price competition for generic drugs, higher regulatory barriers, and poor corporate image. There must be innovations to meet these challenges. Pharmaceutical companies have taken a series of response measures. However, criticisms by critics have long tarnished pharmaceutical companies’ reputation. This series consists of two parts, the first part will discuss the criticism of pharmaceutical companies, and summarizes the support and objection basis of these criticisms. The second part will discuss the current challenges facing pharmaceutical companies and the response they are taking to address the recent brain drain and the introduction of new business models to deal with the recent brain drain and the decline of new drugs entering clinical trials. Some recent drug discoveries Successful examples.